ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,007Medicare Part D Prescriptions Filled, Including Refills

Rank: 445 out of 2170

$540K Total Retail Price of All Prescriptions

Rank: 387 out of 2170

289 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 289 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 289 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,874 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LEVOTHYROXINE SODIUM 276 234 1 5
FUROSEMIDE 248 231 2 6
SERTRALINE HCL 217 191 3 25
METOPROLOL TARTRATE 216 206 4 10
OMEPRAZOLE 207 187 5 2
POTASSIUM CHLORIDE 181 165 6 16
MIRTAZAPINE 177 131 7 46
DIVALPROEX SODIUM 174 154 8 91
LANTUS 160 123 9 51
DONEPEZIL HCL 150 142 10 32
LISINOPRIL 149 148 11 3
SIMVASTATIN 149 136 11 1
ESCITALOPRAM OXALATE 149 142 11 75
NOVOLOG 139 113 14 98
NEXIUM 134 116 15 22
CITALOPRAM HBR 134 121 15 19
EXELON 130 130 17 119
JANTOVEN 121 82 18 104
HYDROCODONE-ACETAMINOPHEN 119 99 S3 19 7
AMLODIPINE BESYLATE 119 114 19 4
FENTANYL 105 94 S2 21 87
WARFARIN SODIUM 104 93 22 15
NAMENDA 102 102 23 48
METOPROLOL SUCCINATE 101 90 24 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 88 24 95
GABAPENTIN 98 80 26 14
TAMSULOSIN HCL 92 72 27 33
RISPERIDONE 86 75 28 73
TRAZODONE HCL 84 61 29 38
ISOSORBIDE MONONITRATE ER 84 80 29 50
METFORMIN HCL 74 71 31 8
ADVAIR DISKUS 73 71 32 45
HYDROCHLOROTHIAZIDE 72 58 33 9
IPRATROPIUM-ALBUTEROL 71 70 34 131
DIGOXIN 60 60 35 72
HALOPERIDOL 57 48 36 176
ZOLPIDEM TARTRATE 55 50 37 17
LEVOFLOXACIN 55 47 37 99
OXYCODONE-ACETAMINOPHEN 55 40 S2 37 60
ATENOLOL 53 44 40 23
TRAMADOL HCL 53 42 40 18
VOLTAREN 53 51 40 226
PRAVASTATIN SODIUM 52 35 43 11
TRAVATAN Z 52 50 43 181
SINGULAIR 51 51 45 85
RANITIDINE HCL 50 46 46 40
QUETIAPINE FUMARATE 50 49 46 88
POLYETHYLENE GLYCOL 3350 50 36 46 63
ALLOPURINOL 50 50 46 29
BACLOFEN 50 37 46 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.